PNW Headlines

PsychedelicNewsBreaks

PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
NRx Pharmaceuticals, Inc. (NRXP)
October 6, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Re-files ANDA for Preservative-Free IV Ketamine KETAFREE(TM)
NRx Pharmaceuticals Inc. (NRXP)
September 29, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product
NRx Pharmaceuticals, Inc. (NRXP)
September 24, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical
NRx Pharmaceuticals Inc. (NRXP)
September 8, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join H.C. Wainwright’s 27th Annual Global Investment Conference; CEO Fireside Chat Set for Sept. 8, 2025, 4:30 to 5 p.m. ET
NRx Pharmaceuticals Inc. (NRXP)
September 3, 2025
View More PsychedelicNewsBreaks

PsychedelicNewsWire Articles

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression
NRx Pharmaceuticals, Inc. (NRXP)
September 2, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
NRx Pharmaceuticals, Inc. (NRXP)
August 22, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
NRx Pharmaceuticals, Inc. (NRXP)
July 8, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100
NRx Pharmaceuticals, Inc. (NRXP)
June 27, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage
NRx Pharmaceuticals, Inc. (NRXP)
June 12, 2025
View All PsychedelicNewsWire Articles

Public Press Releases

Filter Releases
Filters
Sector



Remove All Filters
Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}
Load More

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

PsychedelicNewsWire
PsychedelicNewsWire

1108 Lavaca St
Suite 110-PNW
Austin, TX 78701
(512) 354-7000

Copyright © . PsychedelicNewsWire / 1108 Lavaca St Suite 110-PNW Austin, TX 78701 (512) 354-7000 / Disclaimers